3-hydroxyflavone has been researched along with Lung Neoplasms in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 15 (62.50) | 24.3611 |
| 2020's | 5 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Chinnasamy, A; Devadoss, D; Ramar, M | 1 |
| Patel, DK | 1 |
| Eguchi, H; Endo, S; Ikari, A; Kimura, R; Matsunaga, H; Matsunaga, T; Yoshino, Y | 1 |
| Ali, M; Avgenikos, M; Caburet, J; de Meester, JSB; Dheeraj, A; Kaschula, CH; Mishra, D; Sabarwal, A; Singh, RP; Stander, S; van Otterlo, WAL; van Rooyen, JC | 1 |
| Li, Y; Liu, T; Shi, Z; Sun, J; Tian, G | 1 |
| Alsheikh, HA; Elhamamsy, AR; Kammerud, SC; Mattheyses, AL; Metge, BJ; Samant, RS; Shevde, LA; Weeks, SE | 1 |
| Chen, L; Meng, WS; Meng, ZL; Shi, B; Wang, LF | 1 |
| Fan, KJ; Liu, Y; Tian, XD; Wang, B; Yang, B | 1 |
| Grzanka, A; Grzanka, D; Hałas-Wiśniewska, M; Klimaszewska-Wiśniewska, A | 1 |
| Singh, RP; Tabasum, S | 1 |
| Bishayee, K; Boujedaini, N; Khuda-Bukhsh, AR; Mukherjee, A; Sikdar, S | 1 |
| Choi, YW; Manikandan, R; Ramesh, B; Ravichandran, N; Suresh, G; Vijaiyan Siva, G | 1 |
| Hyun, JW; Kang, KA; Piao, MJ | 1 |
| Khan, N; Mukhtar, H | 1 |
| Afaq, F; Athar, M; Diamond, AC; Elmets, CA; Kappes, JC; Katiyar, SK; Pal, HC; Strickland, LR | 1 |
| Chae, S; Hyun, JW; Kang, KA; Kwon, TK; Madduma Hewage, SR; Oh, MC; Piao, MJ; Ryu, YS | 1 |
| Chang, JH; Chien, MH; Chow, JM; Chung, CL; Hung, WY; Kao, SJ; Lee, WJ | 1 |
| Chao, CH; Chiang, TA; Lee, XY; Liao, YC; Shih, YW | 1 |
| Ramesh, B; Ravichandran, N; Siva, GV; Suresh, G | 1 |
| Hirayama, M; Kawakami, K; Konishi, T; Nakajima, Y; Nishida, H; Tatewaki, N | 1 |
| Afaq, F; Khan, N; Khusro, FH; Mukhtar, H; Mustafa Adhami, V; Suh, Y | 1 |
| Dwyer, J; Katsouyanni, K; Lagiou, A; Lagiou, P; Peterson, J; Samoli, E; Trichopoulos, D | 1 |
| Mursu, J; Nurmi, T; Pukkala, E; Salonen, JT; Tuomainen, TP; Voutilainen, S | 1 |
| Barraj, LM; Cutler, GJ; Harnack, LJ; Jacobs, DR; Mink, PJ; Nettleton, JA; Robien, K; Ross, JA; Scrafford, CG | 1 |
1 review(s) available for 3-hydroxyflavone and Lung Neoplasms
| Article | Year |
|---|---|
Dietary agents for prevention and treatment of lung cancer.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Catechin; Curcumin; Flavonoids; Flavonols; Humans; Indoles; Isothiocyanates; Lung Neoplasms; Plant Extracts; Polyphenols | 2015 |
23 other study(ies) available for 3-hydroxyflavone and Lung Neoplasms
| Article | Year |
|---|---|
Galangin, a dietary flavonol inhibits tumor initiation during experimental pulmonary tumorigenesis by modulating xenobiotic enzymes and antioxidant status.
Topics: Animals; Antioxidants; Carcinogenesis; Flavonoids; Lung Neoplasms; Male; Mice; Xenobiotics | 2018 |
Medicinal Importance, Pharmacological Activities, and Analytical Aspects of Engeletin in Medicine: Therapeutic Benefit Through Scientific Data Analysis.
Topics: Animals; Anti-Inflammatory Agents; Endometritis; Female; Flavonols; Humans; Lung Neoplasms; Medicine, Traditional; Mice | 2023 |
Increase in Anticancer Drug-Induced Toxicity by Fisetin in Lung Adenocarcinoma A549 Spheroid Cells Mediated by the Reduction of Claudin-2 Expression.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Claudin-2; Flavonoids; Flavonols; Humans; Hypoxia; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Tumor Microenvironment | 2022 |
A novel 4'-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; ErbB Receptors; Flavonoids; Flavonols; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; STAT3 Transcription Factor | 2022 |
Engeletin suppresses lung cancer progression by inducing apoptotic cell death through modulating the XIAP signaling pathway: A molecular mechanism involving ER stress.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Disease Progression; Endoplasmic Reticulum Stress; Flavonols; Gene Expression Regulation, Neoplastic; Glycosides; Humans; Lung Neoplasms; Male; Mice; Mitochondria; Mitochondrial Proteins; Signal Transduction; Transcription Factor CHOP; Tumor Burden; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2020 |
Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis.
Topics: Animals; Cell Line, Tumor; Cell Nucleolus; Drug Screening Assays, Antitumor; Drug Synergism; Flavones; Flavonols; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 4 or More Rings; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; RNA Polymerase I; RNA, Ribosomal; Triple Negative Breast Neoplasms | 2021 |
Carnosic acid and fisetin combination therapy enhances inhibition of lung cancer through apoptosis induction.
Topics: Abietanes; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Inhibition of human lung cancer proliferation through targeting stromal fibroblasts by dihydromyricetin.
Topics: Antineoplastic Agents; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Flavonols; Humans; Lung Neoplasms; MAP Kinase Signaling System; Platelet-Derived Growth Factor; Receptors, Platelet-Derived Growth Factor; Stromal Cells | 2017 |
Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Topics: A549 Cells; Actins; Antineoplastic Agents; Apoptosis; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flavonoids; Flavonols; Gene Expression Profiling; Humans; Lung Neoplasms; Neoplasm Metastasis; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vimentin | 2018 |
Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition.
Topics: AC133 Antigen; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Drug Synergism; Epithelial-Mesenchymal Transition; Erlotinib Hydrochloride; Flavonoids; Flavonols; Humans; Hyaluronan Receptors; Lung Neoplasms; Neoplasm Invasiveness; Phenotype; Stem Cells | 2019 |
Flavonol isolated from ethanolic leaf extract of Thuja occidentalis arrests the cell cycle at G2-M and induces ROS-independent apoptosis in A549 cells, targeting nuclear DNA.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Division; Cell Survival; Disease Models, Animal; DNA, Neoplasm; Dose-Response Relationship, Drug; Flavonols; G2 Phase; Humans; Lung Neoplasms; Mice; Plant Extracts; Plant Leaves; Reactive Oxygen Species; Thuja | 2014 |
Fisetin modulates mitochondrial enzymes and apoptotic signals in benzo(a)pyrene-induced lung cancer.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Benzo(a)pyrene; Flavonoids; Flavonols; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lipid Peroxidation; Lung Neoplasms; Mice; Mitochondria; Oxidative Stress; Signal Transduction | 2014 |
Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Cell Survival; Flavonoids; Flavonols; Humans; Intracellular Space; Lung Neoplasms; Mitochondria; Reactive Oxygen Species; Signal Transduction | 2015 |
Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cadherins; Cell Line, Tumor; Cell Movement; Cells, Cultured; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Flavonoids; Flavonols; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Melanoma; Mice, Nude; Mutation; Neoplasm Invasiveness; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Sorafenib; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Death; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Flavonoids; Flavonols; Humans; Lung Neoplasms; Mitochondria; Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Signal Transduction | 2016 |
Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonols; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Protein Kinase Inhibitors; Reactive Oxygen Species | 2017 |
Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Down-Regulation; Enzyme Inhibitors; Flavonoids; Flavonols; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Signal Transduction; Urokinase-Type Plasminogen Activator | 2009 |
Fisetin, a novel flavonol attenuates benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice.
Topics: Analysis of Variance; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Benzo(a)pyrene; Cell Proliferation; Flavonoids; Flavonols; Lipid Peroxidation; Lung; Lung Neoplasms; Male; Mice; Oxidative Stress; Proliferating Cell Nuclear Antigen | 2011 |
Persimmon leaf extract inhibits the ATM activity during DNA damage response induced by Doxorubicin in A549 lung adenocarcinoma cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Survival; Diospyros; DNA Damage; DNA-Binding Proteins; Doxorubicin; Flavonols; G2 Phase; Humans; Lung Neoplasms; Phosphorylation; Plant Extracts; Plant Leaves; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Tumor Suppressor Proteins | 2011 |
Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinase Kinases; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Eukaryotic Initiation Factor-4E; Flavonoids; Flavonols; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; mTOR Associated Protein, LST8 Homolog; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases, 70-kDa; Stem Cells; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2012 |
Flavonoid intake in relation to lung cancer risk: case-control study among women in Greece.
Topics: Case-Control Studies; Female; Flavanones; Flavonoids; Flavonols; Fruit; Greece; Humans; Logistic Models; Lung Neoplasms; Middle Aged; Risk Factors; Smoking; Vegetables | 2004 |
Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study.
Topics: Anthocyanins; Colorectal Neoplasms; Feeding Behavior; Finland; Flavanones; Flavones; Flavonoids; Flavonols; Follow-Up Studies; Humans; Incidence; Life Style; Lung Neoplasms; Male; Middle Aged; Neoplasms; Odds Ratio; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Risk Factors; Smoking | 2008 |
Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study.
Topics: Aged; Anthocyanins; Breast Neoplasms; Digestive System Neoplasms; Feeding Behavior; Female; Flavanones; Flavones; Flavonoids; Flavonols; Humans; Iowa; Isoflavones; Lung Neoplasms; Middle Aged; Neoplasms; Odds Ratio; Postmenopause; Proanthocyanidins; Prospective Studies; Risk Assessment; Risk Factors; Smoking; Surveys and Questionnaires | 2008 |